GFAP and migraine disorder: The aim of this study is to evaluate serum levels of NfL and GFAP in patients with episodic migraine (EM) and chronic migraine (CM) in comparison with healthy age-matched controls to clarify the correlation between migraine and axonal/glial damage and to explore the utility of these biomarkers in the clinical practice.